Entero Therapeutics Ownership | Who Owns Entero Therapeutics?
Entero Therapeutics Ownership Summary
Entero Therapeutics is owned by 1.11% institutional investors, and 98.89% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.36% of its assets in Entero Therapeutics shares.
Institutional Shareholders
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2022 | 15 | - | 533,210 | -2.51% | 1 | 85.63% | 7 | - | 2 | - |
| Mar 31, 2022 | 15 | -6.25% | 546,962 | -23.58% | 1 | 51.30% | 7 | -12.50% | 2 | -50.00% |
| Dec 31, 2021 | 16 | 14.29% | 715,710 | 33.20% | 1 | 119.09% | 8 | -42.86% | 4 | - |
| Sep 30, 2021 | 14 | - | 537,339 | - | 1 | - | 14 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Extended Market Index | 10.04K | 0.36% | -91.00 |
| Vanguard Institutional Extnd Mkt Idx Tr | 4.54K | 0.16% | - |
| Fidelity Series Total Market Index | 717.00 | 0.03% | - |
| Spartan Extended Market Index Pool E | 91.00 | 0.00% | 91.00 |
| SSgA U.S. Extended Market Index Class I | 5.00 | 0.00% | -1.00 |
| State St US Extended Mkt Indx NL Cl C | 5.00 | 0.00% | - |
| NT Ext Equity Mkt Idx Fd - NL | 1.00 | - | - |
| NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 1.00 | - | - |
| SSgA U.S. Total Market Index Strategy | 1.00 | - | - |
| NT Ext Equity Mkt Idx Fd - L | 1.00 | - | -1.00 |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2024 | SAPIRSTEIN JAMES | Chairman and CEO | Sell | $735.92 |
| Apr 01, 2024 | Romano Sarah | Chief Financial Officer | Sell | $317.21 |
| Mar 15, 2024 | SAPIRSTEIN JAMES | Chairman and CEO | Sell | $9.36K |
| Mar 15, 2024 | Romano Sarah | Chief Financial Officer | Sell | $5.56K |
| Jan 12, 2024 | Romano Sarah | Chief Financial Officer | Sell | $411.60 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2024 Q2 | - | 2 |
| 2024 Q1 | - | 4 |
| 2023 Q4 | - | 2 |
| 2023 Q3 | - | 4 |
| 2023 Q2 | - | 2 |
FWBI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools